ENHANCE: A Randomized, Double-blind, Multicenter Study Comparing Magrolimab in Combination with Azacitidine versus Azacitidine Plus Placebo in Treatment-naïve Patients with Higher Risk Myelodysplastic Syndrome.

  • Wei, Andrew (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)
  • Fong, Chun Yew (Chief Investigator (CI))
  • Kenealy, Melita (Chief Investigator (CI))
  • D'Rozario, James (Chief Investigator (CI))
  • Forsyth, Cecily J (Chief Investigator (CI))
  • Shortt, Jake (Chief Investigator (CI))
  • Hertzberg, Mark S. (Chief Investigator (CI))
  • Bajel, Ashish (Chief Investigator (CI))
  • Kwan, John (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date1/09/2031/12/25


  • Myelodysplastic syndrome
  • Clinical trial